JSB Market Research: Cushings Syndrome Therapeutics - Pipeline Assessment and Market Forecasts to 2019
The industry analysis specialist, has released its new report, “Cushing’s Syndrome Therapeutics - Pipeline Assessment and Market Forecasts to 2019”. The report is an essential source of information and analysis on the global Cushings Syndrome Therapeutics market. See Full Report @ http://bit.ly/1z711In
The industry analysis specialist, has released its new report, “Cushing’s Syndrome Therapeutics - Pipeline Assessment and Market Forecasts to 2019”. The report is an essential source of information and analysis on the global Cushings Syndrome Therapeutics market.
See Full Report @ http://bit.ly/1z711In
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Cushings</strong> <strong>Syndrome</strong> <strong>Therapeutics</strong> - <strong>Pipeline</strong> <strong>Assessment</strong><br />
<strong>and</strong> <strong>Market</strong> <strong>Forecasts</strong> <strong>to</strong> <strong>2019</strong><br />
On 8 th December 2014<br />
Summary<br />
The industry analysis specialist, has released its new report, “Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong><br />
- <strong>Pipeline</strong> <strong>Assessment</strong> <strong>and</strong> <strong>Market</strong> <strong>Forecasts</strong> <strong>to</strong> <strong>2019</strong>”. The report is an essential source of<br />
information <strong>and</strong> analysis on the global <strong>Cushings</strong> <strong>Syndrome</strong> <strong>Therapeutics</strong> market. The report<br />
identifies the key trends shaping <strong>and</strong> driving the global <strong>Cushings</strong> <strong>Syndrome</strong> <strong>Therapeutics</strong><br />
market. The report also provides insights on the prevalent competitive l<strong>and</strong>scape <strong>and</strong> the<br />
emerging players expected <strong>to</strong> significantly alter the market positioning of the current market<br />
leaders. Most importantly, the report provides valuable insights on the pipeline products within<br />
the global <strong>Cushings</strong> <strong>Syndrome</strong> <strong>Therapeutics</strong> sec<strong>to</strong>r. This report is built using data <strong>and</strong><br />
information sourced from proprietary databases, primary <strong>and</strong> secondary research <strong>and</strong> in-house<br />
analysis by GlobalData’s team of industry experts.<br />
You can buy this Report @ http://www.jsbmarketresearch.com/healthcaremedical/r-cushings-syndrome-therapeutics-pipeline-assessment-<strong>and</strong>-marketforecasts-135211<br />
Email ID- contact@jsbmarketresearch.com<br />
Tel No- 91 2241236650<br />
Published by- http:/www.jsbmarketresearch.com/
Scope<br />
The report provides information on the key drivers <strong>and</strong> challenges of the <strong>Cushings</strong> <strong>Syndrome</strong><br />
<strong>Therapeutics</strong> market. Its scope includes -<br />
- Annualized seven key markets (US, France, Germany, Italy, Spain, UK <strong>and</strong> Japan) <strong>Cushings</strong><br />
<strong>Syndrome</strong> <strong>Therapeutics</strong> market revenues data from 2006 <strong>to</strong> 2011, forecast for eight years <strong>to</strong><br />
<strong>2019</strong>.<br />
- <strong>Pipeline</strong> analysis data providing a split across the different phases, mechanisms of action being<br />
developed <strong>and</strong> emerging trends by seven key markets. <strong>Pipeline</strong> c<strong>and</strong>idates fall under major<br />
therapeutic classes.<br />
- Analysis of the current <strong>and</strong> future competition in the seven key countries <strong>Cushings</strong> <strong>Syndrome</strong><br />
<strong>Therapeutics</strong> market.<br />
- Insightful review of the key industry drivers, restraints <strong>and</strong> challenges. Each trend is<br />
independently researched <strong>to</strong> provide a qualitative analysis of its implications.<br />
- Key <strong>to</strong>pics covered include strategic competi<strong>to</strong>r assessment, market characterization, unmet<br />
needs <strong>and</strong> the implications for the <strong>Cushings</strong> <strong>Syndrome</strong> <strong>Therapeutics</strong> market.<br />
- Analysis of key recent licensing <strong>and</strong> partnership agreements in <strong>Cushings</strong> <strong>Syndrome</strong><br />
<strong>Therapeutics</strong> market<br />
Reasons <strong>to</strong> buy<br />
The report will enhance your decision making capability. It will allow you <strong>to</strong> -<br />
- Develop <strong>and</strong> design your in-licensing <strong>and</strong> out-licensing strategies through a review of pipeline<br />
products <strong>and</strong> technologies <strong>and</strong> by identifying the companies with the most robust pipeline.<br />
- Develop business strategies by underst<strong>and</strong>ing the trends shaping <strong>and</strong> driving the global<br />
<strong>Cushings</strong> <strong>Syndrome</strong> <strong>Therapeutics</strong> market.<br />
Email ID- contact@jsbmarketresearch.com<br />
Tel No- 91 2241236650<br />
Published by- http:/www.jsbmarketresearch.com/
- Drive revenues by underst<strong>and</strong>ing the key trends, innovative products <strong>and</strong> technologies,<br />
market segments <strong>and</strong> companies likely <strong>to</strong> impact the global <strong>Cushings</strong> <strong>Syndrome</strong> <strong>Therapeutics</strong><br />
market in future.<br />
- Formulate effective sales <strong>and</strong> marketing strategies by underst<strong>and</strong>ing the competitive<br />
l<strong>and</strong>scape <strong>and</strong> by analyzing the performance of various competi<strong>to</strong>rs.<br />
- Identify emerging players with potentially strong product portfolios <strong>and</strong> create effective<br />
counter-strategies <strong>to</strong> gain a competitive advantage.<br />
- Organize your sales <strong>and</strong> marketing efforts by identifying the market categories <strong>and</strong> segments<br />
that present maximum opportunities for consolidations, investments <strong>and</strong> strategic<br />
partnerships.<br />
- What’s the next big thing in the global <strong>Cushings</strong> <strong>Syndrome</strong> <strong>Therapeutics</strong> market l<strong>and</strong>scape? –<br />
Identify, underst<strong>and</strong> <strong>and</strong> capitalize.<br />
Other industries we cover:<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
Advertising <strong>and</strong> Media<br />
Au<strong>to</strong>motive <strong>and</strong> Parts<br />
Consumer Goods<br />
Healthcare <strong>and</strong> Medical<br />
Finance <strong>and</strong> Banking<br />
Food <strong>and</strong> Beverages<br />
Travel <strong>and</strong> Tourism<br />
Textiles <strong>and</strong> Clothing<br />
SWOT Analysis<br />
Discounts on <strong>Market</strong> <strong>Research</strong> Reports till 31st December, 2014<br />
For more inquiries, contact at +91 - 998 729 5242 /<br />
contact@jsbmarketresearch.com<br />
Email ID- contact@jsbmarketresearch.com<br />
Tel No- 91 2241236650<br />
Published by- http:/www.jsbmarketresearch.com/
Table of Content<br />
2 Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> - Introduction<br />
2.1 Disease Overview<br />
2.1.1 Functions of Cortisol Hormone<br />
2.1.2 Types of Cushing’s <strong>Syndrome</strong><br />
2.2 Epidemiology<br />
2.3 Etiology<br />
2.3.1 Endogenous Cushing’s <strong>Syndrome</strong> Fac<strong>to</strong>rs<br />
2.4 Pathophysiology<br />
2.5 Signs <strong>and</strong> Symp<strong>to</strong>ms<br />
2.6 Commonly Used Diagnostic Tests<br />
2.6.1 Tests <strong>to</strong> Diagnose <strong>Cushings</strong> <strong>Syndrome</strong><br />
2.6.2 Tests <strong>to</strong> Find the Cause of <strong>Cushings</strong> <strong>Syndrome</strong><br />
2.7 Treatment <strong>and</strong> Management Options for Cushing’s <strong>Syndrome</strong><br />
2.7.1 Exogenous Cushing’s <strong>Syndrome</strong> Treatment<br />
2.7.2 Endogenous Cushing’s <strong>Syndrome</strong> Treatment<br />
2.8 GlobalData <strong>Pipeline</strong> Report Guidance<br />
3 Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> - <strong>Market</strong> Characterization<br />
3.1 Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> <strong>Market</strong> Size (2006-2011) - Global<br />
Email ID- contact@jsbmarketresearch.com<br />
Tel No- 91 2241236650<br />
Published by- http:/www.jsbmarketresearch.com/
3.2 Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> <strong>Market</strong> Forecast (2011-<strong>2019</strong>) - Global<br />
3.3 Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> <strong>Market</strong> Size (2006-2011) - The US<br />
3.4 Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> <strong>Market</strong> Forecast (2011-<strong>2019</strong>) - The US<br />
3.5 Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> <strong>Market</strong> Size (2006-2011) - France<br />
3.6 Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> <strong>Market</strong> Forecast (2011-<strong>2019</strong>) - France<br />
3.7 Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> <strong>Market</strong> Size (2006-2011) - Germany<br />
3.8 Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> <strong>Market</strong> Forecast (2011-<strong>2019</strong>) - Germany<br />
3.9 Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> <strong>Market</strong> Size (2006-2011) - Italy<br />
3.10 Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> <strong>Market</strong> Forecast (2011-<strong>2019</strong>) - Italy<br />
3.11 Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> <strong>Market</strong> Size (2006-2011) - Spain<br />
3.12 Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> <strong>Market</strong> Forecast (2011-<strong>2019</strong>) - Spain<br />
3.13 Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> <strong>Market</strong> Size (2006-2011) - The UK<br />
3.14 Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> <strong>Market</strong> Forecast (2011-<strong>2019</strong>) - The UK<br />
3.15 Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> <strong>Market</strong> Size (2006-2011) - Japan<br />
3.16 Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> <strong>Market</strong> Forecast (2011-<strong>2019</strong>) - Japan<br />
3.17 Drivers <strong>and</strong> Barriers for the Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> <strong>Market</strong><br />
3.17.1 Drivers for the Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> <strong>Market</strong><br />
3.17.2 Barriers for the Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> <strong>Market</strong><br />
3.18 Opportunity <strong>and</strong> Unmet Need Analysis<br />
3.19 Key Takeaway<br />
Email ID- contact@jsbmarketresearch.com<br />
Tel No- 91 2241236650<br />
Published by- http:/www.jsbmarketresearch.com/
4 Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> - Competitive <strong>Assessment</strong><br />
4.1 Overview<br />
4.1.1 Strategic Competi<strong>to</strong>r <strong>Assessment</strong><br />
4.2 Off-labeled Drugs in the Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> <strong>Market</strong><br />
4.2.1 Steroidogenesis Inhibi<strong>to</strong>rs<br />
4.2.2 Ke<strong>to</strong>conazole<br />
4.2.3 Metyrapone<br />
4.2.4 Mi<strong>to</strong>tane<br />
4.2.5 Dopamine Recep<strong>to</strong>r Agonist<br />
4.2.6 Cabergoline<br />
4.3 Key Takeaway<br />
5 Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> - <strong>Pipeline</strong> <strong>Assessment</strong><br />
5.1 Overview<br />
5.2 Strategic <strong>Pipeline</strong> <strong>Assessment</strong><br />
5.3 Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> <strong>Pipeline</strong> - <strong>Pipeline</strong> by Phases of Development<br />
5.3.1 Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> - Regula<strong>to</strong>ry Filed<br />
5.3.2 Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> - Phase III <strong>Pipeline</strong><br />
5.3.3 Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> - Phase II <strong>Pipeline</strong><br />
5.3.4 Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> - Preclinical<br />
5.4 Technology Trends Analytic Framework<br />
Email ID- contact@jsbmarketresearch.com<br />
Tel No- 91 2241236650<br />
Published by- http:/www.jsbmarketresearch.com/
5.5 Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> <strong>Market</strong> - <strong>Pipeline</strong> by Mechanism of Action<br />
5.6 Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> - Promising Drugs in Clinical Development<br />
5.7 Molecule Profile for Promising Drugs in Clinical Development<br />
5.7.1 Pasireotide (SOM230)<br />
5.7.2 Korlym (mifepris<strong>to</strong>ne)<br />
5.7.3 Mifedren (HRA052015)<br />
5.8 Key Takeaway<br />
6 Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> - Clinical Trials Mapping<br />
6.1 Clinical Trials by Region <strong>and</strong> Country<br />
6.2 Clinical Trials by Phase<br />
6.3 Clinical Trials by Trial Status<br />
6.4 Clinical Trials Mapping by Sponsors<br />
6.5 Prominent Sponsors<br />
6.6 Top Companies Participating in Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> Clinical Trials<br />
7 Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> - Strategic <strong>Assessment</strong><br />
7.1 Key Events Impacting the Future <strong>Market</strong><br />
7.2 Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong>: Implications for Future <strong>Market</strong><br />
8 Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> <strong>Market</strong> - Future Players<br />
8.1 Introduction<br />
Email ID- contact@jsbmarketresearch.com<br />
Tel No- 91 2241236650<br />
Published by- http:/www.jsbmarketresearch.com/
8.2 Company Profiles<br />
8.2.1 Novartis AG (Novartis)<br />
8.2.2 Corcept <strong>Therapeutics</strong> Incorporated<br />
8.2.3 HRA Pharma, SA<br />
8.2.4 Ipsen S.A<br />
8.2.5 Samaritan Pharmaceuticals, Inc.<br />
9 Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> - Licensing <strong>and</strong> Partnership Deals<br />
10 Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> - Appendix<br />
10.1 <strong>Market</strong> Definitions<br />
10.2 Acronyms<br />
10.3 <strong>Research</strong> Methodology<br />
10.3.1 Coverage<br />
10.3.2 Secondary <strong>Research</strong><br />
10.3.3 Forecasting<br />
10.3.4 Primary <strong>Research</strong><br />
10.3.5 Expert Panel Validation<br />
10.4 Contact Us<br />
10.5 Disclaimer<br />
10.6 Bibliography<br />
Email ID- contact@jsbmarketresearch.com<br />
Tel No- 91 2241236650<br />
Published by- http:/www.jsbmarketresearch.com/
List Of Tables<br />
Table 1: Complications Associated With Cushing’s <strong>Syndrome</strong><br />
Table 2: Cushing’s <strong>Syndrome</strong> Prevalence in Major <strong>Market</strong>s<br />
Table 3: Currently Used Drugs In Cushing’s <strong>Syndrome</strong><br />
Table 4: Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> <strong>Market</strong>, Global, Revenue ($m), 2006-2011<br />
Table 5: Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> <strong>Market</strong>, Global, Forecast ($m), 2011-<strong>2019</strong><br />
Table 6: Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> <strong>Market</strong>, The US, Revenue ($m), 2006-2011<br />
Table 7: Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> <strong>Market</strong>, The US, Forecast ($m), 2011-<strong>2019</strong><br />
Table 8: Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> <strong>Market</strong>, France, Revenue ($m), 2006-2011<br />
Table 9: Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> <strong>Market</strong>, France, Forecast ($m), 2011-<strong>2019</strong><br />
Table 10: Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> <strong>Market</strong>, Germany, Revenue ($m), 2006-2011<br />
Table 11: Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> <strong>Market</strong>, Germany, <strong>Forecasts</strong> ($m), 2011-<strong>2019</strong><br />
Table 12: Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> <strong>Market</strong>, Italy, Revenue ($m), 2006-2011<br />
Table 13: Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> <strong>Market</strong>, Italy, Forecast ($m), 2011-<strong>2019</strong><br />
Table 14: Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> <strong>Market</strong>, Spain, Revenue ($m), 2006-2011<br />
Table 15: Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> <strong>Market</strong>, Spain, <strong>Forecasts</strong> ($m), 2011-<strong>2019</strong><br />
Table 16: Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> <strong>Market</strong>, The UK, Revenue ($m), 2006-2011<br />
Table 17: Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> <strong>Market</strong>, The UK, <strong>Forecasts</strong> ($m), 2011-<strong>2019</strong><br />
Table 18: Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> <strong>Market</strong>, Japan, Revenue ($m), 2006-2011<br />
Email ID- contact@jsbmarketresearch.com<br />
Tel No- 91 2241236650<br />
Published by- http:/www.jsbmarketresearch.com/
Table 19: Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> <strong>Market</strong>, Japan, <strong>Forecasts</strong> ($m), 2011-<strong>2019</strong><br />
Table 20: Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> - Regula<strong>to</strong>ry Filed, 2011<br />
Table 21: Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> - Phase III <strong>Pipeline</strong>, 2011<br />
Table 22: Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> - Phase II <strong>Pipeline</strong>, 2011<br />
Table 23: Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> - Preclinical Phase <strong>Pipeline</strong>, 2011<br />
Table 24: Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> - Promising Drug in Clinical Development, 2011<br />
Table 25: Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> - Clinical Trials by Country, 2011<br />
Table 26: Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> - Clinical Trials by Phase, 2011<br />
Table 27: Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> - Clinical Trials by Status, 2011<br />
Table 28: Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> - Overall Sponsors, 2011<br />
Table 29: Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> - Prominent Sponsors, 2011<br />
Table 30: Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> - Top Companies Participating in <strong>Therapeutics</strong><br />
Clinical Trials, 2011<br />
Table 31: Novartis AG, <strong>Pipeline</strong>- 2011<br />
Table 32: Corcept <strong>Therapeutics</strong> Incorporated, <strong>Pipeline</strong>- 2011<br />
Table 33: HRA Pharma, SA, <strong>Pipeline</strong>- 2011<br />
Table 34: Ipsen S.A, <strong>Pipeline</strong> - 2011<br />
Table 35: Samaritan Pharmaceuticals, Inc., <strong>Pipeline</strong> - 2011<br />
Table 36: Cushing’s <strong>Syndrome</strong> -Global, Deals, 2011<br />
Email ID- contact@jsbmarketresearch.com<br />
Tel No- 91 2241236650<br />
Published by- http:/www.jsbmarketresearch.com/
List Of Figures<br />
Figure 1: Etiology of Cushing’s <strong>Syndrome</strong><br />
Figure 2: Treatment Algorithm for Cushing’s <strong>Syndrome</strong><br />
Figure 3: Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> <strong>Market</strong>, Global, Revenue ($m), 2006-2011<br />
Figure 4: Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> <strong>Market</strong>, Global, Forecast ($m), 2011-<strong>2019</strong><br />
Figure 5: Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> <strong>Market</strong>, The US, Forecast ($m), 2006-2011<br />
Figure 6: Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> <strong>Market</strong>, The US, Forecast ($m), 2011-<strong>2019</strong><br />
Figure 7: Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> <strong>Market</strong>, France, Revenue ($m), 2006-2011<br />
Figure 8: Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> <strong>Market</strong>, France, Forecast ($m), 2011-<strong>2019</strong><br />
Figure 9: Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> <strong>Market</strong>, Germany, Revenue ($m), 2006-2011<br />
Figure 10: Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> <strong>Market</strong>, Germany, Forecast ($m), 2011-<strong>2019</strong><br />
Figure 11: Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> <strong>Market</strong>, Italy, Revenue ($m), 2006-2011<br />
Figure 12: Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> <strong>Market</strong>, Italy, Forecast ($m), 2011-<strong>2019</strong><br />
Figure 13: Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> <strong>Market</strong>, Spain, Revenue ($m), 2006-2011<br />
Figure 14: Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> <strong>Market</strong>, Spain, Forecast ($m), 2011-<strong>2019</strong><br />
Figure 15: Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> <strong>Market</strong>, The UK, Revenue ($m), 2006-2011<br />
Figure 16: Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> <strong>Market</strong>, The UK, Forecast ($m), 2011-<strong>2019</strong><br />
Figure 17: Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> <strong>Market</strong>, Japan, Revenue ($m), 2006-2011<br />
Figure 18: Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> <strong>Market</strong>, Japan, <strong>Forecasts</strong> ($m), 2011-<strong>2019</strong><br />
Email ID- contact@jsbmarketresearch.com<br />
Tel No- 91 2241236650<br />
Published by- http:/www.jsbmarketresearch.com/
Figure 19: Opportunity <strong>and</strong> Unmet Need in the Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> <strong>Market</strong><br />
Figure 20: Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> - Strategic Competi<strong>to</strong>r <strong>Assessment</strong>, 2011<br />
Figure 21: Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> - <strong>Pipeline</strong> by Phase of Development, 2011<br />
Figure 22: Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> - Technology Trends Analytics Framework, 2011<br />
Figure 23: Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> - Technology Trends Analytics Framework -<br />
Description, 2011<br />
Figure 24: Cushing’s syndrome <strong>Therapeutics</strong> - <strong>Pipeline</strong> by Mechanism of Action, 2011<br />
Figure 25: Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> - Clinical Trials by Country, 2011<br />
Figure 26: Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> - Clinical Trials by Phase, 2011<br />
Figure 27: Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> - Clinical Trials by Status, 2011<br />
Figure 28: Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> - Overall Sponsors, 2011<br />
Figure 29: Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> - Prominent Sponsors, 2011<br />
Figure 30: Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> - Top Companies Participating in <strong>Therapeutics</strong><br />
Clinical Trials, 2011<br />
Figure 31: Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> <strong>Market</strong>, Drivers <strong>and</strong> Barriers, 2011<br />
Figure 32: Implications for Future <strong>Market</strong> Competition in the Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong><br />
<strong>Market</strong>, 2011<br />
Figure 33: Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> <strong>Market</strong> - Clinical <strong>Pipeline</strong> by Company, 2011<br />
Figure 34: GlobalData <strong>Market</strong> Forecasting Model<br />
Email ID- contact@jsbmarketresearch.com<br />
Tel No- 91 2241236650<br />
Published by- http:/www.jsbmarketresearch.com/
Report Price:<br />
Licence Type<br />
Price<br />
PDF $ 3995<br />
Site Licence $ 7990<br />
Enterprise Wide Licence $ 11985<br />
Related Reports:<br />
Athlete’s Foot <strong>Therapeutics</strong> - <strong>Pipeline</strong> <strong>Assessment</strong> <strong>and</strong> <strong>Market</strong> <strong>Forecasts</strong> <strong>to</strong> <strong>2019</strong><br />
HIV-Associated Diarrhea <strong>Therapeutics</strong> - <strong>Pipeline</strong> <strong>Assessment</strong> <strong>and</strong> <strong>Market</strong> <strong>Forecasts</strong> <strong>to</strong> <strong>2019</strong><br />
Syphilis <strong>Therapeutics</strong> - <strong>Pipeline</strong> <strong>Assessment</strong> <strong>and</strong> <strong>Market</strong> <strong>Forecasts</strong> <strong>to</strong> <strong>2019</strong><br />
Respira<strong>to</strong>ry Syncytial Virus (RSV) Prophylactic - <strong>Pipeline</strong> <strong>Assessment</strong> <strong>and</strong> <strong>Market</strong> <strong>Forecasts</strong> <strong>to</strong> <strong>2019</strong><br />
Vaginitis <strong>Therapeutics</strong> - <strong>Pipeline</strong> <strong>Assessment</strong> <strong>and</strong> <strong>Market</strong> <strong>Forecasts</strong> <strong>to</strong> <strong>2019</strong><br />
Clostridium difficile Infection (CDI) <strong>Therapeutics</strong> - <strong>Pipeline</strong> <strong>Assessment</strong> <strong>and</strong> <strong>Market</strong> <strong>Forecasts</strong> <strong>to</strong> <strong>2019</strong><br />
Aspergillosis <strong>Therapeutics</strong> - <strong>Pipeline</strong> <strong>Assessment</strong> <strong>and</strong> <strong>Market</strong> <strong>Forecasts</strong> <strong>to</strong> <strong>2019</strong><br />
Email ID- contact@jsbmarketresearch.com<br />
Tel No- 91 2241236650<br />
Published by- http:/www.jsbmarketresearch.com/
Haemophilus Influenzae Type B (Hib) Vaccine - <strong>Pipeline</strong> <strong>Assessment</strong> <strong>and</strong> <strong>Market</strong> <strong>Forecasts</strong> <strong>to</strong> <strong>2019</strong><br />
Gonorrhea <strong>Therapeutics</strong> - <strong>Pipeline</strong> <strong>Assessment</strong> <strong>and</strong> <strong>Market</strong> <strong>Forecasts</strong> <strong>to</strong> <strong>2019</strong><br />
Hepatitis B <strong>Therapeutics</strong> - <strong>Pipeline</strong> <strong>Assessment</strong> <strong>and</strong> <strong>Market</strong> <strong>Forecasts</strong> <strong>to</strong> <strong>2019</strong><br />
You can order this report by calling on +91 - 998 7295 242 or mail us<br />
your contact details at contact@jsbmarketresearch.com<br />
About <strong>JSB</strong> <strong>Market</strong> <strong>Research</strong>:-<br />
<strong>JSB</strong> market research is a leading player in the market of research report distribution. It is ones<strong>to</strong>p-shop<br />
for all information related <strong>to</strong> market research for any sec<strong>to</strong>r of the industry. Along<br />
with providing in-depth analysis though reports, <strong>JSB</strong> market research also provides regular<br />
updates of the market though newsletters. Our reports are a well-researched work of market<br />
researchers with an extensive knowledge <strong>and</strong> a good level of market experience.<br />
To know more on Cushing’s <strong>Syndrome</strong> <strong>Therapeutics</strong> - <strong>Pipeline</strong> <strong>Assessment</strong> <strong>and</strong><br />
<strong>Market</strong> <strong>Forecasts</strong> <strong>to</strong> <strong>2019</strong><br />
http://www.jsbmarketresearch.com/healthcare-medical/r-cushingssyndrome-therapeutics-pipeline-assessment-<strong>and</strong>-market-forecasts-135211<br />
Email ID- contact@jsbmarketresearch.com<br />
Tel No- 91 2241236650<br />
Published by- http:/www.jsbmarketresearch.com/